Background: Little is known of biological functions of DNA polymerase (pol) in human cells. Results: pol promotes replication through the common oxidation product, thymine glycol, in human cells. Conclusion: pol active site can accommodate the considerable distortion imposed by thymine glycol at the extension step. Significance: pol may function in translesion synthesis opposite a variety of DNA lesions.
In humans, a number of translesion synthesis (TLS) 2 DNA polymerases (polymerases) promote replication through DNA lesions. To determine the genetic control of TLS that occurs during DNA replication in human cells, we have used a duplex plasmid system in which bidirectional replication initiates from an SV40 origin in the presence of T antigen, and the genetic control of TLS can be examined opposite a DNA lesion carried on the leading or the lagging strand DNA template. Using this plasmid system, we have shown that TLS occurs about equally frequently on the two DNA strands and that they share the same genetic control (1) (2) (3) . For example, opposite a cis-syn TT dimer, pol promotes error-free TLS, whereas polymerases and provide alternate pathways of mutagenic TLS (2) . To verify whether these observations with the SV40 plasmid system reflect TLS mechanisms that operate during chromosomal replication, we determined the genetic control of error-free and mutagenic TLS opposite UV-induced cyclobutane pyrimidine dimers formed at the various TT, TC, and CC dipyrimidine sequences in the cII gene carried in the chromosome in big blue mouse embryonic fibroblast cells. As expected from results with the SV40-based plasmid, we showed that polymerases and function in alternate mutagenic TLS pathways and that pol promotes an error-free mode of TLS (2) . Similarly, from analyses of TLS opposite another UV-induced DNA lesion, a TT photoproduct carried on the SV40-based plasmid, or from analyses of the genetic control of error-free and mutagenic TLS opposite photoproducts formed in the cII gene in mouse cells, we concluded that TLS opposite this lesion also operates identically in the plasmid and chromosomal cII gene (3) . Furthermore, our analyses of the UV sensitivity of human or mouse cells depleted of TLS polymerases have corroborated the conclusions for the roles of various polymerases in TLS opposite UV-induced DNA lesions (4) .
To ascertain further that the genetic control of TLS as determined from studies with the SV40-based plasmid is indicative of the mechanisms that operate during cellular replication, we examined the genetic control of TLS opposite a cis-syn TT dimer and opposite a TT photoproduct carried on the leading or the lagging strand template of a duplex plasmid in which bidirectional replication initiates from the Epstein-Barr virus (EBV) origin of replication (oriP). Replication of EBV plasmid has been studied thoroughly in human cells, and except for the requirement of the EBV-encoded EBNA1 protein, which binds to oriP but has no DNA helicase or any other enzymatic activity (5, 6) , the replication of EBV plasmid is controlled by the same cellular processes that govern chromosomal replication (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . Our observations that the results of TLS and mutagenesis studies with the EBV plasmid resemble those derived from studies with SV40 plasmid, and that they correspond with the genetic studies of the chromosomal cII gene in mouse cells, have indicated that TLS studies with the SV40 plasmid are as informative of TLS mechanisms that operate during chromosomal replication as those with the EBV plasmid (17) . Because it is less cumbersome to construct the SV40 plasmid, we use this plasmid system for TLS studies.
Thymine glycol (TG), the most common oxidative product of thymine, is generated from reaction of thymine with hydroxyl radicals resulting from aerobic respiration or from exposure to chemical oxidants or ionizing radiation (18 -21) . It has been estimated that ϳ400 TG lesions are formed per day in human cells (18) , and TG is one of the predominant lesions produced by ionizing radiation (19, 21) . Because of the addition of hydroxyl groups at C5 and C6, TG loses its aromatic character and becomes nonplanar (22) (23) (24) ; consequently, the C5 methyl group protrudes in the axial direction and prevents the base 5Ј to TG from stacking above it. Thus, TG presents a strong block to synthesis by replicative and repair DNA polymerases; and we have shown previously that TLS opposite a TG lesion carried on the leading or lagging strand DNA template of SV40-based plasmid in human cells occurs in a predominantly error-free fashion and that polymerases and function together in promoting error-free replication through the lesion (1). In addition, based upon biochemical and structural considerations, we proposed a role for pol at the nucleotide insertion step (25) and pol at the subsequent extension step (26) . However, because siRNA depletion of pol or pol conferred only an ϳ50% reduction in TLS frequency, and because the frequency of mutagenic TLS increases 2-fold to ϳ5%, we inferred that in addition to a pol/pol-dependent error-free pathway, TLS through a TG lesion in human cells occurs via another pathway that promotes TLS in a weakly mutagenic manner (1) .
To identify the DNA polymerase(s) involved in mediating the other, more error-prone, TLS pathway opposite TG, we examined the roles of pol and pol in TLS opposite TG in human cells. Human pol shares sequence homology with the A-family DNA polymerases characterized by Escherichia coli DNA polymerase I (pol I). However, unlike pol I, pol lacks the 3Ј 3 5Ј exonuclease and 5Ј 3 3Ј exonuclease activities, and in addition to a C-terminal A-family polymerase domain, pol contains an N-terminal ATPase/helicase domain and a large central domain that lies between the ATPase and polymerase domains (27) . Also, unlike E. coli pol I, pol synthesizes DNA with a low fidelity, generating single base substitution errors at the rate of 2.4 ϫ 10 Ϫ3 (28). In its structural characteristics, human pol, which is comprised of 2590 residues, resembles Drosophila melanogaster Mus308, a 2060-residue protein, and the two proteins share considerable homology in the N-terminal ATPase/helicase and the C-terminal polymerase domain (27) . However, human pol harbors three inserts in its polymerase domain that are absent in Drosophila Mus308 (27) .
In addition to pol, humans encode another pol-related A-family DNA polymerase, pol. Unlike pol, pol lacks the N-terminal helicase domain, and the three inserts in the polymerase domain of pol differ from the inserts present in pol (27, 29) . Inserts 1 and 2 are much shorter in pol than in pol, and insert 3 is also much shorter in pol and lies in a position entirely different from that in pol (29) . Similar to pol, pol is a low fidelity enzyme, synthesizing DNA with single base substitution error rates of 3.5 ϫ 10 Ϫ3 (30).
Biochemical studies have indicated that both pol and pol can replicate through the TG lesion by inserting an A opposite the lesion and by extending from the inserted dNTP (31, 32) . In this study, we provide evidence that TLS opposite the TG lesion in human cells is mediated by two alternate pathways, the polymerases /-dependent error-free pathway and another pathway in which pol alone functions in a mutagenic manner. pol, however, plays no role in TLS opposite this lesion. Thus, despite the fact that in vitro, pol can replicate through the TG lesion, it is not used for replicating through this lesion in human cells. We discuss the possible implications of this and other observations for TLS in human cells.
EXPERIMENTAL PROCEDURES

Construction of Plasmid Vectors Containing a Thymine
Glycol-The 16-mer oligonucleotides containing the major (5R,6S) or minor (5S,6R) forms of TG ( Fig. 1A) , were synthesized and purified. The in-frame target sequence of the lacZЈ gene in the resulting vectors and the construction of SV40based heteroduplex vectors carrying the TG lesion have been described previously (1) .
Translesion Synthesis Assays and Mutational Analyses of TLS Products from Human Cells-Human fibroblasts (MRC5, obtained from Coriell Cell Repository) were grown in DMEM (Invitrogen) containing 10% FBS (Invitrogen) and penicillin/ streptomycin (Invitrogen). Cells were plated in 6-well plates at 70% confluence (approximately, 3 ϫ 10 5 cells per well) and transfected with 100 pmol of synthetic duplex siRNAs using Lipofectamine 2000 reagent (Invitrogen). The silent select siRNAs were purchased from Ambion. The target sequences for pol and pol are shown in Table 1 and the primer sequences used for RT-PCR to verify the efficiency of their siRNA depletion are shown in Table 2 . The siRNA target sequences for other TLS polymerases have been described previously (2) . The details of TLS and mutational analyses in human cells have been described previously (1) .
Expression of Wild Type or Catalytic Mutant of pol in Normal Human Fibroblasts and in Yeast-Wild type C-terminal portions of pol, comprised of residues 1708 -2590, or its catalytic mutant containing D2540A,E2541A mutations in the active site residues were subcloned into p3ϫFLAG-CMV (Sigma) harboring the zeocin resistance gene. The vectors were transfected into normal human fibroblast cells by Lipofectamine 2000 reagent (Invitrogen). After 24 h incubation, 50 g/ml of zeocin (Invitrogen) were added to the culture media. After 3 days of incubation, cells were washed with PBS and continuously cultured with the media containing 25 g/ml of zeocin for ϳ2 weeks. pol expression was checked by Western Primer sequences used for RT-PCR to verify the efficiency of siRNA knockdown of human pol and pol blot with 10 g/ml of antibodies against human pol (rabbit polyclonal from Santa Cruz Biotechnology and Abcam). We established several independent stable cell lines expressing recombinant pol-(1708 -2590) and catalytic mutant pol-(1708 -2590). All the different cell lines showed similar levels of expression of pol-(1708 -2590) and the catalytic mutant pol-(1708 -2590), and the recombinant proteins were expressed to the same level as endogenous pol. Even though the cell lines are not clonal, to avoid overexpression of recombinant proteins, we used the antibiotic selection protocol. Following stabilized expression of recombinant proteins, after more than 4 passages under stable selection, in addition to determining that the expression levels of wild type and catalytically inactive pol-(1708 -2590) were very similar to that of endogenous pol, we verified that the effects of recombinant proteins on TLS opposite the TG lesion in 3 independent stable cell lines were identical.
For purification, human pol comprised of residues 1708 -2590 was cloned in-frame with GST under control of the GAL: PGK promoter in plasmid pPOL507. The GST-tagged pol protein was expressed in yeast cells and purified as described (33) . After affinity purification of GST-pol, the GST tag was cleaved by Prescission protease.
RT-PCR and Western Blot Analysis for Checking the Efficiency of siRNA Knockdown in Human Fibroblasts-48 h after siRNA transfection (Table 1) total RNA was extracted using the Qiagen RNasy extraction kit (Qiagen) and 100 ng of total RNA were used for RT-PCR analysis. RT-PCR was performed with a Qiagen one-step RT-PCR kit following the manufacturer's protocols. Primer sequences used for RT-PCR of pol, pol, and GAPDH are shown in Table 2 . The details for siRNA sequences used for knockdown of other TLS polymerases and for RT-PCR analyses have been published previously (2) . For Western blot analyses, 48 h after siRNA transfection, cells were washed with PBS buffer and lysed with RIPA buffer (1ϫ PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). After a 1-h incubation on ice, the cellular mixture was centrifuged, and the supernatant was collected. Equivalent amounts (ϳ30 g) of prepared cellular extracts were separated on a 10% SDS-polyacrylamide gel and transferred to a PVDF membrane (Bio-Rad). The membranes were probed with 10 g/ml of antibodies against human pol (rabbit polyclonal from Santa Cruz Biotechnology and Abcam) and with 10 g/ml of human pol antibodies (rabbit polyclonal from Abnova) followed by appropriate secondary antibodies conjugated with horseradish peroxidase. The signals were detected using ECL Plus (Amersham Biosciences). To confirm equal loading, blots were stripped with stripping solution (Chemicon) and reprobed with 2 g/ml of anti-␤-tubulin antibody (Santa Cruz Biotechnology).
DNA Polymerase Assays-DNA substrates consisted of a 32 Plabeled oligonucleotide primer annealed to a 75-nucleotide oligonucleotide DNA template by heating a mixture of primer/ template at a 1:1.5 molar ratio to 95°C and allowing it to cool to room temperature for several hours. The template 75-mer oligonucleotide contained the sequence 5Ј-AGC AAG TCA CCA ATG TCT AAG AGT TCG TAG TAT GCC TAC ACT GGA GTA CCG GAG CAT CGT CGT GAC TGG GAA AAC-3Ј in which the underlined residue was either an undam-aged T or a TG. For examining the incorporation of dATP, dTTP, dGTP, or dCTP nucleotides individually, or of all 4 dNTPs, and for steady-state kinetic analyses of nucleotide insertion opposite the undamaged T or TG, a 44-mer primer 5Ј-GTT TTC CCA GTC ACG ACG ATG CTC CGG TAC TCC AGT GTA GGC AT-3Ј was used. The standard DNA synthesis reaction (5 l) contained 25 mM Tris⅐HCl (pH 7.5), 5 mM MgCl 2, 1 mM dithiothreitol, 100 g/ml of BSA, 10% glycerol, 10 nM DNA substrate, and pol (0.375 nM). For nucleotide incorporation assays, 10 M dATP, dTTP, dCTP, or dGTP (Roche Applied Science) were used, and for examining synthesis through the TG lesion all 4 dNTPs (10 M each) were used. Reactions were carried out for 10 min at 37°C.
Steady-State Kinetic Analysis-Steady-state kinetic analyses for deoxynucleotide incorporation were performed as described (33) . Gel band intensities of the substrate and products of the deoxynucleotide incorporation reactions were quantified by using a PhosphorImager and IMAGEQUANT software (Molecular Dynamics). The observed rate of deoxynucleotide incorporation, v obs , was determined by dividing the amount of product formed by the reaction time and protein concentration. The v obs was graphed as a function of the deoxynucleotide concentration, and the data were fit to the Michaelis-Menten
). From the best fit curve, the apparent K m and k cat steady-state kinetics parameter were obtained for dNTP incorporation by pol and the efficiencies of nucleotide incorporation (k cat /K m ) were determined.
RESULTS
Requirement of pol for Replication through a TG Lesion in
Human Cells-TG exists in two forms: 5R,6S and 5S,6R (Fig.  1A) . The details of TLS and mutation analyses with the SV40 plasmid carrying a site-specific TG lesion on the leading strand or the lagging strand DNA template have been described previously (1) . Briefly, because the lacZ gene in the TG-containing DNA strand carries the Kan ϩ gene, and because the base sequence in this strand is in-frame, TLS through the DNA lesion produces a blue colony on LB/Kan plates with isopropyl 1-thio-␤-D-galactopyranoside and X-Gal (Fig. 1B) , and the frequency of blue colonies among the total kan ϩ colonies gives an estimate of TLS frequency. However, the other DNA strand, which has no DNA lesion, has an SpeI sequence opposite from the TG lesion, which puts the lacZ sequence out of frame. Because lesion bypass by template switching would occur by DNA synthesis using the SpeI-containing strand as a template, the Kan ϩ colonies resulting from template switching will be white ( Fig. 1B) . In addition to template switching, white Kan ϩ colonies could result also from lesion removal processes such as nucleotide excision repair or base excision repair ( Fig. 1B) .
To identify the TLS polymerase(s) involved in the pol/polindependent pathway for replicating through the TG lesion, we examined the effects of siRNA depletion of various DNA polymerases, including pol and pol (Fig. 2) , products of the POLQ and POLN genes, respectively. Polymerases and are both A-family polymerases, but unlike E. coli pol I, which is also an A-family polymerase, both of these polymerases lack a 3Ј 3 5Ј proofreading exonuclease activity, and they synthesize DNA MAY 9, 2014 • VOLUME 289 • NUMBER 19
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with a low fidelity (27) . Biochemical studies have indicated that both pol and pol can synthesize DNA on templates containing a TG lesion (31, 32) .
In human cells treated with control (NC) siRNA, TLS through a 5R,6S TG lesion occurs with a frequency of 24% on the leading strand and 22% on the lagging strand ( Table 3 ). The siRNA depletion of pol resulted in a 50% reduction in TLS frequency for the lesion carried on either DNA strand (Table 3) ; TLS frequencies, however, were not affected in cells depleted for pol (Table 3 ). Because the siRNA treatment was highly effective in the depletion of pol, the lack of any effect of pol depletion on TLS is not due to significant levels of pol still being present (Fig. 2 ). As we have shown previously, siRNA depletion of pol or pol results in a 50% reduction in TLS frequencies, irrespective of whether the TG lesion was present on the leading or lagging strand (1) . The simultaneous depletion of pol with pol or with the Rev3 or Rev7 subunits of Pol, led to a large reduction in TLS frequencies ( Table 3) . The low levels of TLS (4 -5%) that still remain after simultaneous depletions of pol with pol or pol are likely to be due to residual protein levels that persist when assays require the simultaneous knockdowns of two polymerases; however, the possibility of another TLS polymerase involvement cannot be definitively excluded. Because compared with the effects of individual depletions of polymerases , , or on TLS frequencies, simultaneous depletion of pol with pol or with pol confers a highly significant reduction in TLS frequencies (p Ͻ Ͻ 0.001), we conclude a role of pol in mediating TLS opposite TG via a pathway that operates independently of polymerases and (Fig. 3) .
We also compared the effects of pol depletion on TLS opposite the 5S,6R isoform of TG. As shown in Table 4 , depletion of pol or pol resulted in a 50% reduction in TLS frequencies, and pol depletion also conferred a similar level of reduction in TLS opposite the 5S,6R TG lesion. Thus, poland pol/pol-mediated TLS pathways contribute equally to promoting replication through the 5R,6S or 5S,6R isoforms of the TG lesion.
Mutagenicity of pol-mediated TLS in Human Cells-As we have shown previously, TLS opposite the 5R,6S TG lesion occurs in a predominantly error-free fashion, as only ϳ2% of TLS events incur mutations (1) . Because the frequency of mutagenic TLS rises to ϳ5% in cells depleted of pol or pol, these Oxidation of thymine generates primarily the (5R,6S) isomer and the less frequently formed (5S,6R) isomer. B, strategy for TLS assays. In the SV40based duplex plasmid, the leading or lagging DNA strand templates containing a site-specific TG also carries the wild type kanamycin gene (Kan ϩ ). Because the lesion-containing LacZ sequence is in-frame, TLS through the TG will produce a blue colony on LB/Kan plates with isopropyl 1-thio-␤-Dgalactopyranoside and X-Gal. However, the other DNA strand without the lesion has an SpeI sequence opposite the TG lesion, which puts the LacZ gene out-of-frame. Thus, replication through the TG lesion by template switching (TS) will pick up the out-of-frame SpeI sequence, as a result of which the white colonies among the Kan ϩ colonies would result from template switching. White colonies among Kan ϩ could arise also from the removal of the TG lesion by base excision repair (BER) or nucleotide excision repair (NER). polymerases function in an error-free mode of TLS at the TG lesion (Table 5 ). On the other hand, pol depletion confers a large reduction in mutagenic TLS events. In pol-depleted cells, among a total of 768 TLS products analyzed for both the DNA strands, only a single mutational alteration was observed; by contrast, a total of 12 mutagenic events were found among 545 TLS products analyzed from cells treated with control siRNA ( Table 5 ). From these observations, we conclude that replication through a TG lesion occurs by two independent pathways in which pol and pol function together in an errorfree pathway, and pol mediates the mutagenic pathway. Because in cells depleted for pol and pol, only the pol pathway would remain functional, our observation that in the 1,149 TLS products analyzed from cells depleted for pol and pol, 45 of 56 total mutational events incurred a base change at the lesion site, whereas in only 11 of them were mutations found at the next 5Ј template base, has indicated that despite the very considerable distortion imposed by TG on the next 5Ј template base, Pol can carry out predominantly error-free synthesis opposite this 5Ј template base (Table 5) . N-terminal ATPase/Helicase Domain of pol Is Dispensable for TLS Opposite TG-Human pol is a 290-kDa protein comprised of an N-terminal ATPase/helicase domain, a large central domain, and a C-terminal polymerase domain (Fig. 4 ) that shares high sequence similarity with A-family DNA polymerases such as E. coli pol I. Purified full-length pol exhibits a single-stranded DNA-dependent ATPase activity (34) . Unlike prokaryotic A-family polymerases and unlike even the eukaryotic pol homolog Mus308 in Drosophila, human and mouse Pol harbor insertion elements 1, 2, and 3, in the polymerase domain. The effects of deletions of these insertion elements on DNA synthesis have been examined in a protein comprised of residues 1792-2590, which lacks the DNA helicase and central domains but retains the DNA polymerase domain and DNA synthesis activity (35) . Any further shortening of the N-terminal portion, however, inactivates polymerase function (35) . The removal of insertion loops 2 or 3 results in a considerable reduction in the ability of the pol-(1792-2590) protein to synthesize DNA; the removal of insertion loop 1, however, has much less of an adverse effect on DNA synthesis (35) .
To determine whether the N-terminal ATPase/helicase domain was required for the ability of pol to function in TLS, we expressed pol containing the C-terminal polymerase domain in human cells. Because our studies of different deletions have indicated that pol comprised of residues 1708 -2590, which encodes an ϳ100-kDa protein, shows the maximal polymerase activity on undamaged DNA and because any further deletion of the N terminus reduced polymerase activity, we chose this construct for TLS studies in human cells (Fig. 4) . Furthermore, the observation that purification of pol from HeLa cells yields an ϳ100 kDa pol protein, which shows proficient DNA synthesis activity on undamaged DNA and on DNA containing an abasic site (36) , raised the possibility that the C-terminal polymerase domain was sufficient for promoting replication through the TG lesion in human cells. MAY 9, 2014 • VOLUME 289 • NUMBER 19
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TLS opposite a TG lesion carried on the leading strand template in SV40-based plasmid was examined in human fibroblasts from which genomic pol has been depleted by siRNA treatment and that carry the vector expressing pol-(1708 -2590) or which have the control vector that lacks pol. Because the siRNA is directed against an mRNA sequence in the N terminus of full-length pol, which is not present in the pol-(1708 -2590) mRNA (Fig. 4) , only the full-length genomic pol is depleted in siRNA-treated cells. As shown in Table 6 , TLS in cells treated with control (NC) siRNA carrying the vector lacking pol, or the vector expressing pol-(1708 -2590), occurred with a frequency of ϳ20%.
Using pol antibody, we verified that pol-(1708 -2590) was expressed at about the same level as the genomic full size pol. Interestingly, in the presence of endogenous pol, the additional expression of pol-(1708 -2590) did not increase the frequency of TLS events ( Table 6 ). Such an outcome might be expected if the role of pol in TLS was modulated via a multiprotein assemblage and not by pol alone, because then excess pol will remain non-functional in TLS.
Importantly, whereas in cells in which genomic pol has been depleted by siRNA treatment and that carry the control vector lacking pol, TLS occurred with a frequency of ϳ10%, in cells expressing pol-(1708 -2590), TLS occurred at normal levels (ϳ20%) ( Table 6 ). Thus, in cells from which full-length genomic pol has been depleted, only the C-terminal polymerase domain is sufficient for restoring pol-dependent TLS opposite the TG lesion, indicating that the ATPase/helicase domain as well as most of the central domain is dispensable for the ability of pol to function in TLS.
Requirement of DNA Polymerase Activity of pol for TLS in Human Cells-To ascertain that pol functions in TLS opposite TG as a DNA polymerase, we examined TLS in human cells that express a pol-(1708 -2590) D2540A,E2541A mutant protein defective in DNA synthesis. In human cells from which genomic pol has been depleted by siRNA treatment and that express wild type pol or catalytically inactive pol-(1708 -2590), TLS occurs with a frequency of ϳ20 and 10%, respectively (Table 6 ). Because TLS in cells expressing the catalytically inactive pol is reduced to the same level as in cells that carry the control vector, pol functions in TLS as a DNA polymerase ( Table 6 ). Similar to that in cells in which genomic pol has been depleted and that carry the control vector, mutagenic TLS is greatly reduced in cells expressing catalytically inactive pol-(1708 -2590) ( Table 7) .
Our observation that TLS is reduced to the same level in cells expressing the catalytic mutant of pol-(1708 -2590) as in the absence of pol, indicates that the pol catalytic mutant does not act as a dominant-negative mutation. One possibility for the lack of the dominant-negative effect of the pol catalytic mutation on TLS mediated by the pol/pol pathway is that these catalytically active polymerases are able to displace the catalytically inactive pol from DNA at the lesion site.
Catalytic Efficiency and Fidelity of DNA Synthesis by pol-(1708 -2590)-For evaluating the role of pol-(1708 -2590) in DNA synthesis opposite TG, we examined its ability to insert dATP, dTTP, dGTP, or dCTP opposite TG, and to synthesize DNA through the TG lesion in the presence of all 4 dNTPs. pol-(1708 -2590) inserts dATP opposite the lesion site (Fig. 5) , and in the presence of all 4 dNTPs, it replicates through the TG lesion. Interestingly, the pattern of nucleotide insertion opposite TG differs from that opposite the undamaged T residue. In contrast to the near absence of dTTP or dGTP insertion opposite TG, these nucleotides are incorporated more frequently opposite undamaged T. In the presence of all 4 dNTPs, pol-(1708 -2590) extends from the nucleotide inserted opposite TG. The apparently higher fidelity of pol opposite TG than opposite undamaged T was verified by steady-state kinetic analyses. As shown in Table 8 , pol-(1708 -2590) inserts dATP opposite TG or undamaged T with a similar catalytic efficiency (k cat /K m ). However, opposite the undamaged T, pol-(1708 -2590) inserts dTTP with a ϳ200-fold reduction in efficiency, whereas opposite the TG lesion, dTTP is inserted with an about 1600-fold reduced efficiency ( Table 8 ). The incorporation of dGTP also occurs with a somewhat lower efficiency opposite the TG lesion than opposite the undamaged T (Table 8) . The wild type pol construct comprised of residues 1708 -2590 and its polymerase defective counterpart harboring D2540A,E2541A mutations in the active site residues are shown, and the ability of these pol constructs to carry out TLS opposite TG in human cells is indicated. The wild type and mutant pol constructs, comprised of residues 1708 -2590, lack the siRNA target sequence present in the N-terminal region of full-length pol. 
DISCUSSION
Role of TLS in Replicative Bypass of TG Lesion-TLS opposite the TG lesion carried in SV40-based duplex plasmid occurs with a frequency of about 20 -25%. In addition to the 20 -25% Kan ϩ blue colonies that arise from TLS, the remaining 75-80% of colonies, which are Kan ϩ white, could arise from the removal of the TG lesion by DNA repair processes or result from template switching during plasmid replication (Fig. 1B) . Because the human cells used for these studies are proficient in nucleotide excision repair and base excision repair, a considerable number of TG lesions could have been removed by these DNA repair processes. Replication through the TG lesion could occur by template switching, in which rather than carrying out DNA synthesis directly opposite the DNA lesion as occurs at the lesion site during TLS, the newly synthesized strand switches template and uses the non-damaged DNA strand as a template for synthesizing DNA.
pol/pol and pol Mediate Alternate Pathways for Promoting Replication through a TG Lesion-Previously, we showed that pol and pol function together in promoting replication through a TG lesion; however, because siRNA depletion of pol or the Rev3 or Rev7 subunits of pol conferred only a 50% reduction in TLS frequency, the existence of an alternate pathway(s) was inferred, which we now show is mediated by pol. Because by contrast to the increased frequency of mutagenic TLS that occurs in cells depleted of pol or pol, mutagenic TLS is almost completely absent in cells depleted of pol, we conclude that replication through the TG lesion can occur by an error-free pol/pol pathway or by an alternative pol-dependent mutagenic pathway (Fig. 3) . Whereas in the pol/pol pathway, following the insertion of an A opposite TG, pol would extend from the TG:A base pair, in the other pathway, pol would carry out both steps of TLS, generating ϳ5% mutationally altered TLS products. Interestingly, even though extension from the TG:A base pair present a considerable impediment due to the displacement of the 5Ј template base, in pol-mediated TLS, errors predominantly occur at the lesion site and not at the next 5Ј template base. The ability of pol to function at both the insertion and extension steps and to carry out predominantly error-free synthesis opposite the 5Ј template base is rather remarkable, and it suggests that the pol active site is equipped to accommodate distorting DNA lesions. It also raises the possibility that pol TLS function is modulated further by additional protein factors.
Dispensability of the N-terminal ATPase/Helicase Domain for TLS-Although pol has an N-terminal helicase domain, a long central domain, and a C-terminal polymerase domain, our deletion analyses have indicated that pol comprised of C-terminal residues (1708 -2590), which lacks the ATPase/helicase domain and a large part of the central domain, is sufficient for mediating TLS through the TG lesion in human cells. Thus the ATPase/helicase function of pol is dispensable for its role in TLS and a large part of the central domain is also not necessary. Because the frequency of mutagenic TLS is not elevated in cells expressing only the C-terminal polymerase domain, this pol protein replicates through the TG lesion with the same fidelity as full-length pol.
Our observation that the expression of pol-(1708 -2590) in cells also expressing endogenous full-length pol does not increase the frequency of TLS events opposite TG (Table 6 ), raises the possibility that TLS polymerases function in lesion bypass as components of multiprotein assemblies and not alone. In that case, an increase in the expression of a TLS polymerase or in the expression of any of the other components will confer no further increase in the levels of multiprotein assembly. As a result, TLS frequencies may remain impervious to an increase in the level of a TLS polymerase or any other component of such a multiprotein assembly. Our kinetic studies with pol-(1708 -2590) have indicated that it incorporates the correct A opposite TG with the same catalytic efficiency (k cat /K m ) as opposite an undamaged T; but it incorporates the wrong nucleotides much less efficiently opposite TG than opposite undamaged T. The more efficient ability of pol to discriminate against incorrect nucleotides opposite TG suggests that its active site can accommodate and stabilize the correct nucleotide much better than the incorrect ones opposite the TG lesion than opposite an undamaged T residue.
Specificity in the Roles of TLS Polymerases for Replicating through a TG Lesion-Even though TLS polymerases such as and can synthesize DNA opposite TG (32, 37) , human cells utilize polymerases , , and for replicating through it and not polymerases and . Moreover, because biochemical studies have indicated that pol is highly efficient for inserting an A opposite TG and it extends from the (5R,6S) TG:A base pair with only a modest reduction (ϳ15-fold) in efficiency (37) , whereas pol shows a reduced efficiency for inserting an A opposite TG and in extending (25) , why are biochemical studies not reflective of the polymerases that are utilized in human cells for TLS opposite TG, and why do human cells utilize pol and pol rather than using pol? Similarly, why is only pol required, but not pol, for TLS opposite TG in human cells? Such considerations raise the possibility that the TLS polymerases used for replicating through a particular DNA lesion are not entirely selected on the basis of their catalytic efficiencies; hence, the more efficient polymerase does not necessarily out compete a TLS polymerase that is catalytically less efficient. Such a possibility suggests that the targeting of TLS polymerases to lesion sites is predicated by additional protein factors that assemble at lesion sites and that functionally interact with TLS polymerases. Furthermore, post-translational modifications of TLS polymerases and other proteins that associate with TLS polymerases in multiprotein assemblies could affect which of the TLS polymerases are used for replicating through a particular type of DNA lesion in human cells.
Requirement of TLS Polymerases for Inserting a Nucleotide Opposite TG: Possible Implications-Although a number of replicative and repair DNA polymerases have been shown to insert an A opposite TG, they are blocked at extending from the TG:A pair (26, 38) . That is because the addition of hydroxyl groups at the 5 and 6 positions of TG renders the damaged base nonplanar; consequently, the C5 methyl group protrudes in the axial direction, which prevents the base 5Ј to TG from stacking above it. The crystal structure of replicative RB69 DNA polymerase has shown that the templating TG remains intra-helical and forms a regular Watson-Crick base pair with the incoming A nucleotide (39) . As had been predicted from computer simulations, in the crystal structure, the C5 methyl group of TG prevents the stacking of the next 5Ј templating residue such that the incorporation of the next incoming nucleotide is inhibited (39) .
In summary, we conclude that replication through the TG lesion in human cells occurs by pol/poland pol-mediated pathways in which TLS polymerases carry out nucleotide insertion opposite TG and the subsequent extension step (Fig. 3) . Thus, despite the fact that biochemical and structural studies have indicated that a number of replicative and repair polymerases can insert an A opposite TG using Watson-Crick base pairing, the inference that TLS polymerases carry out the nucleotide insertion step of TLS opposite TG implies that the replicative polymerases are actively excluded from the TLS process. That may occur if the replicative polymerases are made to disengage from the replisome at the lesion site, rendering them unable to carry out any DNA synthesis.
TABLE 8 Catalytic efficiency of nucleotide incorporation opposite undamaged T or the 5R,6S form of TG by human pol
The kinetic parameters for C incorporation opposite T and TG could not be determined because of very poor efficiency. In the last column, the numbers in parentheses indicate the fold-reduction in efficiency. 
